Zimmer Biomet Holdings, Inc. (ZBH) Comparison with companies in other sectors?

Zimmer Biomet Holdings, Inc. has a share price of 197.85M. You can analyze Zimmer Biomet Holdings, Inc. (ZBH) competitors across different market sectors through stock heatmaps.

What are ZBH's NET and operating margins?

Zimmer Biomet Holdings, Inc. (ZBH) operating margin is around 0.17, and net profit margin is approximately 0.12 as of the latest reports.

In what way does ZBH's earnings per share (EPS) trend reflect its financial momentum?

Zimmer Biomet Holdings, Inc. (ZBH) EPS is 4.50 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Zimmer Biomet Holdings, Inc. is 21.32, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Zimmer Biomet Holdings, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Zimmer Biomet Holdings, Inc. like P/E which is 20.87, P/B which is 1.54, and PEG which is 11.61. Compare them with sector averages to evaluate if the stock is priced fairly.

Zimmer Biomet Holdings, Inc.

ZBH•NYSE

Healthcare

Medical - Devices

$95.98

$-1.57(-1.61%)

Zimmer Biomet Holdings, Inc. (ZBH) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$4.50

P/E Ratio

21.32

ROE

0.07%

Net Margin

0.12%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$18.98B

Shares OutstandingTotal number of shares issued

$197.85M

Book Value/ShareNet worth per share

$62.36

Revenue/ShareAnnual revenue per share

$38.71

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$4.5

Net MarginNet income as percentage of revenue

11.86%

Operating MarginOperating income as percentage of revenue

17.04%

ROEReturn on shareholders' equity

7.31%

ROAReturn on total assets

4.12%

ROCEReturn on capital employed

6.60%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$6.78

Cash/ShareCash and equivalents per share

$6.96

FCF YieldFree cash flow as percentage of market cap

7.10%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.96

Dividend YieldAnnual dividend as percentage of stock price

1.000%

Financial Ratios Analysis data is not available for ZBHFinancial Ratios Analysis details for ZBH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ZBHSector Benchmarking details for ZBH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Zimmer Biomet Holdings, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Zimmer Biomet Holdings, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Zimmer Biomet Holdings, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Zimmer Biomet Holdings, Inc.

For Zimmer Biomet Holdings, Inc., essential financial indicators include EPS 4.50, PE 21.32, and ROE 0.07. These key ratios reveal insights into Zimmer Biomet Holdings, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Zimmer Biomet Holdings, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Zimmer Biomet Holdings, Inc.

Metrics like Net Margin 11.86% and ROA 4.12% shed light on how well Zimmer Biomet Holdings, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Zimmer Biomet Holdings, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Zimmer Biomet Holdings, Inc.

Using ratios such as P/B Ratio 1.54 and PEG Ratio 11.61, investors can assess whether Zimmer Biomet Holdings, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Zimmer Biomet Holdings, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Zimmer Biomet Holdings, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.58 and Cash Flow $6.78, provide a snapshot of Zimmer Biomet Holdings, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Zimmer Biomet Holdings, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Zimmer Biomet Holdings, Inc.

Investing in Zimmer Biomet Holdings, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Zimmer Biomet Holdings, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;